Fosfomycin

CHEMBL1757 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
138.1 g/mol
LogP
-1.4
Phase
4

This antibiotic disrupts the early stage of bacterial cell wall construction, and because it works differently from most other antibiotics, it can treat infections caused by bacteria resistant to multiple other drugs. It is most commonly used to treat uncomplicated urinary tract infections, often as a single dose.

الوزن الجزيئي

138,0600 g/mol

LogP

-1,40

TPSA

70,10 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@@H]1O[C@@H]1P(=O)(O)O

InChI

InChI=1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1

Molecular Formula

C3H7O4P

HBD / HBA

2 / 4

الروابط القابلة للدوران

1

الذرات الثقيلة

8

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This antibiotic disrupts the early stage of bacterial cell wall construction, and because it works differently from most other antibiotics, it can treat infections caused by bacteria resistant to multiple other drugs. It is most commonly used to treat uncomplicated urinary tract infections, often as a single dose.

Yes, Fosfomycin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1757. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 446987. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.